Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Activating Transcription Factor 4 (ATF4) Regulates Neuronal Activity by Controlling GABABR Trafficking.

Corona C, Pasini S, Liu J, Amar F, Greene LA, Shelanski ML.

J Neurosci. 2018 Jul 4;38(27):6102-6113. doi: 10.1523/JNEUROSCI.3350-17.2018. Epub 2018 Jun 6.

PMID:
29875265
2.

Characterization of Behavioral, Signaling and Cytokine Alterations in a Rat Neurodevelopmental Model for Schizophrenia, and Their Reversal by the 5-HT6 Receptor Antagonist SB-399885.

Shortall SE, Negm OH, Fowler M, Fairclough LC, Tighe PJ, Wigmore PM, King MV.

Mol Neurobiol. 2018 Sep;55(9):7413-7430. doi: 10.1007/s12035-018-0940-0. Epub 2018 Feb 8.

3.

Development of transcripts regulating dendritic spines in layer 3 pyramidal cells of the monkey prefrontal cortex: Implications for the pathogenesis of schizophrenia.

Dienel SJ, Bazmi HH, Lewis DA.

Neurobiol Dis. 2017 Sep;105:132-141. doi: 10.1016/j.nbd.2017.05.016. Epub 2017 May 31.

4.

Kalirin reduction rescues psychosis-associated behavioral deficits in APPswe/PSEN1dE9 transgenic mice.

Krivinko JM, Erickson SL, Abrahamson EE, Wills ZP, Ikonomovic MD, Penzes P, Sweet RA.

Neurobiol Aging. 2017 Jun;54:59-70. doi: 10.1016/j.neurobiolaging.2017.02.006. Epub 2017 Feb 16.

5.

Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1-PAK3 signaling in neuroplasticity.

Kim MJ, Biag J, Fass DM, Lewis MC, Zhang Q, Fleishman M, Gangwar SP, Machius M, Fromer M, Purcell SM, McCarroll SA, Rudenko G, Premont RT, Scolnick EM, Haggarty SJ.

Mol Psychiatry. 2017 Mar;22(3):417-429. doi: 10.1038/mp.2016.98. Epub 2016 Jul 26.

6.

Palmitoylation of cdc42 Promotes Spine Stabilization and Rescues Spine Density Deficit in a Mouse Model of 22q11.2 Deletion Syndrome.

Moutin E, Nikonenko I, Stefanelli T, Wirth A, Ponimaskin E, De Roo M, Muller D.

Cereb Cortex. 2017 Jul 1;27(7):3618-3629. doi: 10.1093/cercor/bhw183.

PMID:
27365300
7.

EFhd2, a Protein Linked to Alzheimer's Disease and Other Neurological Disorders.

Vega IE.

Front Neurosci. 2016 Mar 31;10:150. doi: 10.3389/fnins.2016.00150. eCollection 2016. Review.

8.

Heterozygous Disruption of Autism susceptibility candidate 2 Causes Impaired Emotional Control and Cognitive Memory.

Hori K, Nagai T, Shan W, Sakamoto A, Abe M, Yamazaki M, Sakimura K, Yamada K, Hoshino M.

PLoS One. 2015 Dec 30;10(12):e0145979. doi: 10.1371/journal.pone.0145979. eCollection 2015.

9.

Spines, synapses, and schizophrenia.

Ramos-Miguel A, Barr AM, Honer WG.

Biol Psychiatry. 2015 Dec 1;78(11):741-3. doi: 10.1016/j.biopsych.2015.08.035. Epub 2015 Sep 3. No abstract available.

PMID:
26542741
10.

Altered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia.

Datta D, Arion D, Corradi JP, Lewis DA.

Biol Psychiatry. 2015 Dec 1;78(11):775-85. doi: 10.1016/j.biopsych.2015.03.030. Epub 2015 Apr 11.

11.

Molecular substrates of altered axonal growth and brain connectivity in a mouse model of schizophrenia.

Mukai J, Tamura M, Fénelon K, Rosen AM, Spellman TJ, Kang R, MacDermott AB, Karayiorgou M, Gordon JA, Gogos JA.

Neuron. 2015 May 6;86(3):680-95. doi: 10.1016/j.neuron.2015.04.003. Epub 2015 Apr 23.

12.

NOMA-GAP/ARHGAP33 regulates synapse development and autistic-like behavior in the mouse.

Schuster S, Rivalan M, Strauss U, Stoenica L, Trimbuch T, Rademacher N, Parthasarathy S, Lajkó D, Rosenmund C, Shoichet SA, Winter Y, Tarabykin V, Rosário M.

Mol Psychiatry. 2015 Sep;20(9):1120-31. doi: 10.1038/mp.2015.42. Epub 2015 Apr 14.

PMID:
25869807
13.

Cytoskeletal regulation by AUTS2 in neuronal migration and neuritogenesis.

Hori K, Nagai T, Shan W, Sakamoto A, Taya S, Hashimoto R, Hayashi T, Abe M, Yamazaki M, Nakao K, Nishioka T, Sakimura K, Yamada K, Kaibuchi K, Hoshino M.

Cell Rep. 2014 Dec 24;9(6):2166-79. doi: 10.1016/j.celrep.2014.11.045. Epub 2014 Dec 18.

14.

Inhibiting geranylgeranyltransferase I activity decreases spine density in central nervous system.

Yuan M, Gao S, Sun C, Chen L, Shi Q, Hu J, Yu R, Zhou X.

Hippocampus. 2015 Mar;25(3):373-84. doi: 10.1002/hipo.22379. Epub 2014 Nov 25.

PMID:
25330763
15.

Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growth.

Duhr F, Déléris P, Raynaud F, Séveno M, Morisset-Lopez S, Mannoury la Cour C, Millan MJ, Bockaert J, Marin P, Chaumont-Dubel S.

Nat Chem Biol. 2014 Jul;10(7):590-7. doi: 10.1038/nchembio.1547. Epub 2014 Jun 1.

PMID:
24880860
16.

MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review.

Forstner AJ, Degenhardt F, Schratt G, Nöthen MM.

Front Mol Neurosci. 2013 Dec 5;6:47. doi: 10.3389/fnmol.2013.00047. Review.

17.

Herbal therapeutics that block the oncogenic kinase PAK1: a practical approach towards PAK1-dependent diseases and longevity.

Maruta H.

Phytother Res. 2014 May;28(5):656-72. doi: 10.1002/ptr.5054. Epub 2013 Aug 14. Review.

PMID:
23943274
18.

Rit subfamily small GTPases: regulators in neuronal differentiation and survival.

Shi GX, Cai W, Andres DA.

Cell Signal. 2013 Oct;25(10):2060-8. doi: 10.1016/j.cellsig.2013.06.002. Epub 2013 Jun 11. Review.

19.

Dizocilpine reduces head diameter of dendritic spines in the hippocampus of adolescent rats.

Han D, Xu L, Xiao H, Prado Schmidt GC, Shi S.

Psychiatry Res. 2013 Nov 30;210(1):351-6. doi: 10.1016/j.psychres.2013.04.025. Epub 2013 Jun 6.

PMID:
23747234
20.

PAK1 protein expression in the auditory cortex of schizophrenia subjects.

Deo AJ, Goldszer IM, Li S, DiBitetto JV, Henteleff R, Sampson A, Lewis DA, Penzes P, Sweet RA.

PLoS One. 2013 Apr 22;8(4):e59458. doi: 10.1371/journal.pone.0059458. Print 2013.

Supplemental Content

Loading ...
Support Center